Dr. Boehm is NIST's Chief of Staff. He provides strategic guidance and advice to the NIST Director and senior leadership to help the institute accomplish its mission by maximizing budgetary resources, expanding partnerships and improving operations.
Prior to becoming Chief of Staff, Dr. Boehm was director of the NIST Program Coordination Office, with 15 years of budget, policy and planning experience. In that role, he served as the primary technical advisor and consultant to the NIST Director and Associate Director for Laboratory Programs, carrying out planning and review of NIST R&D programs in areas of strategic importance to the agency and administration; development and implementation of strategic programs for the institute; and representation of NIST’s interests on boards, committees and interagency policy forums.
Dr. Boehm came to NIST from the Office of Science and Technology Policy (OSTP), Executive Office of the President, where he was responsible for consultation, analysis and policy development regarding science and technology related to multiple issues of homeland and national security, including the development of medical and nonmedical countermeasures against WMD, domestic nuclear defense, engineered threats and emerging infectious diseases, biological and chemical agent decontamination, nuclear defense and detection, international collaborations on homeland security-related S&T, and a number of other issues. Dr. Boehm originally joined OSTP as a AAAS/NTI Fellow in Global Security, an award that provided him the opportunity to work anywhere within the U.S. government on issues related to biological terrorism.
Before joining the federal government, Dr. Boehm was involved in cancer research at Cornell University, where he led a team of researchers studying the role of the cellular protein tissue transglutaminase in cell survival and tumorigenesis. Dr. Boehm received his Ph.D. in 2000 from the University of Nebraska Medical Center, Eppley Institute for Cancer Research, where he studied the role of receptor tyrosine kinase signaling in cell survival.